AIM at Melanoma Foundation
@AIMatMelanoma
Followers
8K
Following
2K
Statuses
9K
Advancing the battle against #melanoma through innovative research, legislative reform, education, & patient/caregiver support.
Global
Joined March 2009
The FDA has accepted the BLA for RP1 (vusolimogene oderparepvec) + nivolumab for advanced melanoma. With Priority Review granted, we’re one step closer to offering hope to patients who have failed previous treatments. Learn more:
0
2
2
Honoring the legacy of President Jimmy Carter, whose brave journey with melanoma inspired millions. His strength, grace, and openness about his battle continue to raise awareness and offer hope. Thank you, President Carter, for showing us true resilience. #JimmyCarter
0
2
3
Big news! The FDA has approved Opdivo Qvantig (nivolumab) as a subcutaneous injection for various solid tumors, including melanoma, lung cancer, and renal cell carcinoma. More convenience and flexibility for patients!
0
1
2
BREAKING NEWS>>Replimune has submitted a Biologics License Application (BLA) to the FDA for RP1 (vusolimogene oderparepvec) combined with nivolumab for the treatment of advanced melanoma in adults.
0
0
4
Moffitt Study Shows Immune Structures in Melanoma Could Help Predict Patient Survival
0
2
5
Join Dr. Geoffrey Lim as he interviews Dr. Jason Luke about adjuvant therapy options. Explore our latest flip magazine for the newest advancements in adjuvant therapy #Melanoma #AdjuvantTherapy #OncologyInsights
0
1
0
🗓 Date: Saturday, November 2, 2024 🕚 Time: 11:00 AM ET | 10:00 AM CT | 9:00 AM MT | 8:00 AM PT 💻 Format: Presented Virtually REGISTER:
0
0
1
We last discussed vaccines in September 2021, and in the three years since, remarkable progress has been made in cancer immunotherapy, including promising vaccines for cancer treatment.
0
1
3
In this compelling episode of “Surviving the Spotlight,” we sit down with Jessica Gilstrap, a melanoma survivor and independent filmmaker, whose inspiring journey from cancer diagnosis to creative success is both moving and motivating.
0
1
4
Did you know colitis affects 30-45% of patients on CTLA-4 inhibitors like ipilimumab (Yervoy)? Symptoms include bloating, cramping, and diarrhea. Most cases are manageable, but it's vital to stay informed!
0
2
1
Know the signs of skin cancer and what you can do now to prevent it
0
0
2
Tobi Sample, ten years ago, faced a diagnosis that would have halted many in their tracks. But not Tobi. To celebrate her 10th anniversary of No Evidence of Disease, she did something most of us only dream of – she climbed Mount Kilimanjaro.
0
0
1
Cancer Diagnosis Rates Remain Lower Than Expected Due to COVID-19 Pandemic via @Pharmacy_Times
0
0
0
Results from a Phase 2 clinical trial for patients with advanced uveal melanoma were presented at ESMO 2024 on September 15, 2024. Among patients with metastatic uveal melanoma, 80% have liver metastasis.
1
1
2
There is good news for patients with melanoma who received immunotherapy. Survival results from a major clinical trial, CheckMate-067, show a sustained benefit after ten years.
0
5
5
New clinical trial data shows that additional options may soon become available for patients with melanoma for whom immunotherapy did not work. The IGNYTE clinical trial results presented at the EMSO Congress showed data for a new oncolytic therapy – RP1.
0
0
1
There is good news for patients with advanced melanoma who received pembrolizumab. Results from a clinical trial after ten years show a sustained overall benefit.
0
1
1
News from ESMO: NADINA Trial Update in Stage III Melanoma
0
1
1
Holly Rowe Gives Update On Desmoplastic Melanoma Cancer Diagnosis - Women's Health - #GoogleAlerts
0
1
1
He thought the blurriness in the corner of his eye was part of aging. It was a rare uveal melanoma
0
1
0